Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
about
Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer.Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma.The association between adult attained height and sitting height with mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC)Multivariate piecewise exponential survival modeling.Genetic variation in IGF1 predicts renal cell carcinoma susceptibility and prognosis in Chinese population.Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures.Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway.Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis.Insulin-like growth factor 2 expression in prostate cancer is regulated by promoter-specific methylation.The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.Environmentally Induced Alterations in the Epigenome Affecting Obesity and Cancer in Minority Populations
P2860
Q35178839-07501BEA-1BB4-428B-B4F8-E7178861DA0FQ36121082-1C0E9A2F-BA21-4600-96B8-01286E3851F1Q36296776-3BDD26FF-74C9-4CA3-962E-8818493F89C7Q37156699-85105F6B-E78A-4050-BACE-1AADADC69896Q37504841-ADE5593A-57A8-4C52-BE57-CD8FDD6B7265Q38434946-048A6DD9-B983-4457-99E5-541BF54E2AEFQ38620751-605CC8D3-E752-4A26-B6B8-41E8517975C5Q38647896-D78F8FD7-82F9-4224-A9E4-227925AA93FBQ40185822-64430756-F15A-46A8-90DD-1866E9E932FBQ41139603-51411450-6790-4F8A-8F46-72E5F697DB0BQ41611110-3ADB45A5-A3C1-4100-8553-5F2F78838ADDQ47138734-FF09C582-75E1-44BB-AB5A-C7D206C643C4Q47295153-052B2107-6CEA-43D1-9AC8-80B1EC9F103FQ53589371-AAF7DBEB-5D84-4B50-86DE-3D797E4423C4Q57433696-2E2F1B34-4BE5-4C38-877C-027F5709FAD1
P2860
Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Insulin-like growth factor pat ...... and prostate cancer survival.
@ast
Insulin-like growth factor pat ...... and prostate cancer survival.
@en
type
label
Insulin-like growth factor pat ...... and prostate cancer survival.
@ast
Insulin-like growth factor pat ...... and prostate cancer survival.
@en
prefLabel
Insulin-like growth factor pat ...... and prostate cancer survival.
@ast
Insulin-like growth factor pat ...... and prostate cancer survival.
@en
P2093
P2860
P50
P356
P1476
Insulin-like growth factor pat ...... and prostate cancer survival.
@en
P2093
Ann W Hsing
Daniel O Stram
J Michael Gaziano
Michael Pollak
Rulla Tamimi
Sara Lindström
Sonja Berndt
Susan M Gapstur
Victoria L Stevens
P2860
P304
P356
10.1093/JNCI/DJU085
P407
P50
P577
2014-06-01T00:00:00Z